Subscribe to Newsletter
Discovery & Development Digital Technologies, Technology and Equipment, Drug Discovery

Human Proteins: Now Free with No Ads

Google’s AI subsidiary, DeepMind, has taken another great leap forward in science, business, and open sourcing by releasing both their AlphaFold algorithm source code and their protein structure database.

AlphaFold is a program created by DeepMind in 2016 to predict protein structures. Four years after its launch, AlphaFold’s predictions matched those of lab techniques. The program has consistently outperformed all its peers – and, over time, itself. It works at rapid speed, and with need of far less resources than any human in a lab.

Both AlphaFold’s v2.0 algorithm and its library of 350,000 protein sequences are now available online for free. DeepMind’s CEO, Demis Hassabis, has expressed his hopes that the pharmaceutical industry will make use of this valuable new resource.

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Angus Stewart

Associate Editor of The Medicine Maker

Between studying for my English undergrad and Publishing master's degrees I was out in Shanghai, teaching, learning, and getting extremely lost. Now I'm expanding my mind down a rather different rabbit hole: the pharmaceutical industry. Outside of this job I read mountains of fiction and philosophy, and I must say, it's very hard to tell who's sharper: the literati, or the medicine makers.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register